Summary:
VITL, a startup in the e-prescribing market, has secured $7.5 million to revamp prescription services for cash-pay clinics, tapping into the growing demand for GLP-1 treatments.
Bullet points:
– VITL secures $7.5 million funding to enhance cash-pay clinic prescription services
– The startup operates an e-prescribing marketplace targeting the expanding GLP-1 market
– VITL aims to modernize prescription processes for cash-pay clinics through innovative technology